Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Romero I, Bast RC Jr. Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapy. Endocrinology. 2012;153:1593–1602.
   PubMed Web of Science ®Google Scholar
• Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA: Cancer J Clin. 2011;61:212–236.
   PubMed Web of Science ®Google Scholar
• Priyadarshini K, Keerthi Aparajitha U. Paclitaxel against cancer: a short review. Med Chem. 2012;2:139–141.
   Google Scholar
• Park S, Kang S, Chen X, et al. Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages. Biomaterials. 2013;34:598–605.
   PubMed Web of Science ®Google Scholar
• Ganguly A, Yang H, Cabral F. Paclitaxel-dependent cell lines reveal a novel drug activity. Mol Cancer Ther. 2010;9:2914–2923.
   PubMed Web of Science ®Google Scholar
• Sperone P, Gorzegno G, Berruti A, et al. Reversible pancytopenia caused by oral letrozole assumption in a patient with recurrent breast cancer. JCO. 2002;20:3747–3748.
   PubMed Web of Science ®Google Scholar
• Cella D, Peterman A, Hudgens S, et al. Measuring the side effects of taxane therapy in oncology: the functional assessment of cancer therapy-taxane (FACT-taxane). Cancer. 2003;98:822–831.
   PubMed Web of Science ®Google Scholar
• Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs. 2001;61:2035–2063.
   PubMed Web of Science ®Google Scholar
• Singh RP, Dhanalakshmi S, Agarwal C, et al. Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy. Oncogene. 2005;24:1188–1202.
   PubMed Web of Science ®Google Scholar
• Singh RP, Gu M, Agarwal R. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis. Cancer Res. 2008;68:2043–2050.
   PubMed Web of Science ®Google Scholar
• Bang CI, Paik SY, Sun DI, et al. Cell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line. Ann Otol Rhinol Laryngol. 2008;117:781–785.
   PubMed Web of Science ®Google Scholar
• Agarwal C, Singh RP, Dhanalakshmi S, et al. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene. 2003;22:8271–8282.
   PubMed Web of Science ®Google Scholar
• Singh RP, Sharma G, Dhanalakshmi S, et al. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis. Cancer Epidemiol Biomark Prevent. 2003;12:933–939.
   PubMed Web of Science ®Google Scholar
• Sharma G, Singh RP, Chan DC, et al. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells. Anticancer Res. 2003;23:2649–2655.
   PubMed Web of Science ®Google Scholar
• Tyagi A, Agarwal C, Harrison G, et al. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages. Carcinogenesis. 2004;25:1711–1720.
   PubMed Web of Science ®Google Scholar
• Pashaiasl M, Khodadadi K, Richings NM, et al. Cryopreservation and long-term maintenance of bovine embryo-derived cell lines. Reprod Fertil Dev. 2013;25:707–718.
   PubMed Web of Science ®Google Scholar
• Gholizadeh-Ghaleh Aziz S, Pashaei-Asl F, Fardyazar Z, et al. Isolation, characterization, cryopreservation of human amniotic stem cells and differentiation to osteogenic and adipogenic cells. PLoS One. 2016;11:e0158281.
   PubMed Web of Science ®Google Scholar
• Novichkova S, Egorov S, Daraselia N. MedScan, a natural language processing engine for MEDLINE abstracts. Bioinformatics (Oxford, England). 2003;19:1699–1706.
   PubMed Web of Science ®Google Scholar
• Nikitin A, Egorov S, Daraselia N, et al. Pathway studio–the analysis and navigation of molecular networks. Bioinformatics (Oxford, England). 2003;19:2155–2157.
   PubMed Web of Science ®Google Scholar
• Yuryev A, Kotelnikova E, Daraselia N. Ariadne's chemeffect and pathway studio knowledge base. Expert Opin Drug Discov. 2009;4:1307–1318.
   PubMed Web of Science ®Google Scholar
• Pashaiasl M, Khodadadi K, Kayvanjoo AH, et al. Unravelling evolution of Nanog, the key transcription factor involved in self-renewal of undifferentiated embryonic stem cells, by pattern recognition in nucleotide and tandem repeats characteristics. Gene. 2016;578:194–204.
   PubMed Web of Science ®Google Scholar
• Pashaiasl M, Ebrahimi M, Ebrahimie E. Identification of the key regulating genes of diminished ovarian reserve (DOR) by network and gene ontology analysis. Mol Biol Rep. 2016;43:923–937.
   PubMed Web of Science ®Google Scholar
• Jordan MA, Wendell K, Gardiner S, et al. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 1996;56:816–825.
   PubMed Web of Science ®Google Scholar
• Milross CG, Mason KA, Hunter NR, et al. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J Natl Cancer Inst. 1996;88:1308–1314.
   PubMed Web of Science ®Google Scholar
• Fan W. Possible mechanisms of paclitaxel-induced apoptosis. Biochem Pharmacol. 1999;57:1215–1221.
   PubMed Web of Science ®Google Scholar
• Ling YH, Yang Y, Tornos C, et al. Paclitaxel-induced apoptosis is associated with expression and activation of c-Mos gene product in human ovarian carcinoma SKOV3 cells. Cancer Res. 1998;58:3633–3640.
   PubMed Web of Science ®Google Scholar
• Cheung CW, Gibbons N, Johnson DW, et al. Silibinin-a promising new treatment for cancer. Anticancer Agents Med Chem. 2010;10:186–195.
   PubMed Web of Science ®Google Scholar
• Pashaei-Asl R, Pashaei-Asl F, et al. The inhibitory effect of ginger extract on ovarian cancer cell line. Appl Syst Biol. 2017;7:241–249.
   Google Scholar
• Zhou L, Liu P, Chen B, et al. Silibinin restores paclitaxel sensitivity to paclitaxel-resistant human ovarian carcinoma cells. Anticancer Res. 2008;28:1119–1127.
   PubMed Web of Science ®Google Scholar
• Deep G, Singh RP, Agarwal C, et al. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin. Oncogene. 2006;25:1053–1069.
   PubMed Web of Science ®Google Scholar
• Tyagi AK, Agarwal C, Chan DC, et al. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells. Oncology Rep. 2004;11:493–499.
   PubMed Web of Science ®Google Scholar
• Ho BY, Lin CH, Apaya MK, et al. Silibinin and paclitaxel cotreatment significantly suppress the activity and lung metastasis of triple negative 4T1 mammary tumor cell in mice. J Tradition Complement Med. 2012;2:301–311.
   PubMedGoogle Scholar
• Gholizadeh-Ghaleh Aziz S, Fathi E, Rahmati-Yamchi M, et al. An update clinical application of amniotic fluid-derived stem cells (AFSCs) in cancer cell therapy and tissue engineering. Artif Cells Nanomed Biotechnol. 2017;45:765–774.
   PubMed Web of Science ®Google Scholar
• Motaali S, Pashaeiasl M, Akbarzadeh A, et al. Synthesis and characterization of smart N-isopropylacrylamide-based magnetic nanocomposites containing doxorubicin anti-cancer drug. Artif Cells Nanomed Biotechnol. 2017;45:560–567.
   PubMed Web of Science ®Google Scholar
• Pashaei-Asl R, Khodadadi K, Pashaei-Asl F, et al. Legionella pneumophila and dendrimers-mediated antisense therapy. Adv Pharm Bull. 2017;7:179–187.
   PubMed Web of Science ®Google Scholar